1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in patient awareness and education levels
5.1.1.2. Growing portion of geriatric population
5.1.1.3. Rising adoption of a sedentary lifestyle and incidence of lifestyle diseases
5.1.2. Restraints
5.1.2.1. Side effects associated with the erectile dysfunction drugs
5.1.3. Opportunities
5.1.3.1. Government reforms and public awareness initiatives in developing nations
5.1.3.2. R&D focused on developments of effective therapies and treatments for erectile dysfunction
5.1.4. Challenges
5.1.4.1. Availability of cost-effective counterfeit drugs
5.2. Cumulative Impact of COVID-19

6. Erectile Dysfunction Drugs Market, by Drug
6.1. Introduction
6.2. Avanafil (Stendra)
6.3. Muse Suppository (Alprostadil)
6.4. Sildenafil (Viagra)
6.5. Tadalafil (Cialis)
6.6. Vardenafil (Levitra, Staxyn)

7. Erectile Dysfunction Drugs Market, by Mode of Administration
7.1. Introduction
7.2. Injections
7.3. Oral
7.4. Topical

8. Erectile Dysfunction Drugs Market, by End-User
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies

9. Americas Erectile Dysfunction Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Erectile Dysfunction Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Erectile Dysfunction Drugs Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Apricus Biosciences Inc.
13.2. Aurobindo Pharma Ltd
13.3. Bayer AG
13.4. Cipla Ltd
13.5. Cristalia Produtos Quimicos Farmaceuticos Ltd.
13.6. Dong-A Pharmaceutical Co. Ltd.
13.7. Dr. Reddys Laboratories Ltd
13.8. Eli Lilly and Company
13.9. Endo International PLC
13.10. Ferring Pharmaceuticals
13.11. Futura Medical PLC
13.12. GlaxoSmithKline PLC
13.13. Johnson & Johnson Services, Inc
13.14. Meda Pharmaceuticals, Inc.
13.15. Metuchen Pharmaceuticals LLC
13.16. Mylan N.V.
13.17. Novartis International AG
13.18. Pfizer, Inc.
13.19. Promedon HQ
13.20. S.K. Chemicals Co. Ltd.
13.21. Teva Pharmaceutical Industries Ltd
13.22. Torrent Pharmaceuticals Ltd
13.23. Vivus, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2020 VS 2027 (%)
FIGURE 4. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2027
FIGURE 6. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY AVANAFIL (STENDRA), 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY AVANAFIL (STENDRA), BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MUSE SUPPOSITORY (ALPROSTADIL), 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MUSE SUPPOSITORY (ALPROSTADIL), BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY SILDENAFIL (VIAGRA), 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY SILDENAFIL (VIAGRA), BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TADALAFIL (CIALIS), 2018-2027 (USD MILLION)
FIGURE 13. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TADALAFIL (CIALIS), BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY VARDENAFIL (LEVITRA, STAXYN), 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY VARDENAFIL (LEVITRA, STAXYN), BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2020 VS 2027 (%)
FIGURE 17. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2020 VS 2027 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2027
FIGURE 19. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY INJECTIONS, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY INJECTIONS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ORAL, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ORAL, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TOPICAL, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
FIGURE 26. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2027
FIGURE 28. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 34. AMERICAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. ARGENTINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. BRAZIL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. CANADA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. MEXICO ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. UNITED STATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. ASIA-PACIFIC ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. AUSTRALIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. CHINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. INDIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. INDONESIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. JAPAN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. MALAYSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. PHILIPPINES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. SINGAPORE ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. SOUTH KOREA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. TAIWAN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. THAILAND ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. FRANCE ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. GERMANY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. ITALY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. NETHERLANDS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. QATAR ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. RUSSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. SAUDI ARABIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. SOUTH AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. SPAIN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. UNITED ARAB EMIRATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. UNITED KINGDOM ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 65. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY DRUG, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY AVANAFIL (STENDRA), BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MUSE SUPPOSITORY (ALPROSTADIL), BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY SILDENAFIL (VIAGRA), BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TADALAFIL (CIALIS), BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY VARDENAFIL (LEVITRA, STAXYN), BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. AMERICAS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 18. ARGENTINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. BRAZIL ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. CANADA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. MEXICO ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. AUSTRALIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. CHINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. INDIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. INDONESIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. JAPAN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. MALAYSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. PHILIPPINES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. SINGAPORE ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. SOUTH KOREA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. TAIWAN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. THAILAND ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. FRANCE ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. GERMANY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. ITALY ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. NETHERLANDS ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. QATAR ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. RUSSIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. SAUDI ARABIA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. SOUTH AFRICA ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. SPAIN ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. UNITED ARAB EMIRATES ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. UNITED KINGDOM ERECTILE DYSFUNCTION DRUGS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: SCORES
TABLE 48. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: BUSINESS STRATEGY
TABLE 49. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: PRODUCT SATISFACTION
TABLE 50. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: RANKING
TABLE 51. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 52. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: MERGER & ACQUISITION
TABLE 53. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 54. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 55. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: INVESTMENT & FUNDING
TABLE 56. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 57. GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

Apricus Biosciences Inc.
Aurobindo Pharma Ltd
Bayer AG
Cipla Ltd
Cristalia Produtos Quimicos Farmaceuticos Ltd.
Dong-A Pharmaceutical Co. Ltd.
Dr. Reddys Laboratories Ltd
Eli Lilly and Company
Endo International PLC
Ferring Pharmaceuticals
Futura Medical PLC
GlaxoSmithKline PLC
Johnson & Johnson Services, Inc
Meda Pharmaceuticals, Inc.
Metuchen Pharmaceuticals LLC
Mylan N.V.
Novartis International AG
Pfizer, Inc.
Promedon HQ
S.K. Chemicals Co. Ltd.
Teva Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Vivus, Inc.